US 11401317
Human-CD123-targeting chimeric receptor ligand and application thereof
granted A61KA61K40/11A61K40/31
Quick answer
US patent 11401317 (Human-CD123-targeting chimeric receptor ligand and application thereof) held by Nanjing Legend Biotech Co., Ltd expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nanjing Legend Biotech Co., Ltd
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4217, A61P